KYMR logo

Kymera Therapeutics, Inc. (KYMR) Shareholders Equity

Annual Shareholders Equity:

$835.62M+$440.65M(+111.56%)
December 31, 2024

Summary

  • As of today, KYMR annual stockholders equity is $835.62 million, with the most recent change of +$440.65 million (+111.56%) on December 31, 2024.
  • During the last 3 years, KYMR annual shareholders equity has risen by +$375.98 million (+81.80%).
  • KYMR annual shareholders equity is now at all-time high.

Performance

KYMR Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Quarterly Shareholders Equity:

$946.26M-$25.22M(-2.60%)
September 30, 2025

Summary

  • As of today, KYMR quarterly stockholders equity is $946.26 million, with the most recent change of -$25.22 million (-2.60%) on September 30, 2025.
  • Over the past year, KYMR quarterly shareholders equity has increased by +$53.33 million (+5.97%).
  • KYMR quarterly shareholders equity is now -2.60% below its all-time high of $971.48 million, reached on June 30, 2025.

Performance

KYMR Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

KYMR Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+111.6%+6.0%
3Y3 Years+81.8%+84.5%
5Y5 Years+2309.9%+221.1%

KYMR Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+111.6%-2.6%+139.6%
5Y5-Yearat high+2309.9%-2.6%+266.6%
All-TimeAll-Timeat high+2309.9%-2.6%+2629.0%

KYMR Shareholders Equity History

DateAnnualQuarterly
Sep 2025
-
$946.26M(-2.6%)
Jun 2025
-
$971.48M(+23.6%)
Mar 2025
-
$786.23M(-5.9%)
Dec 2024
$835.62M(+111.6%)
$835.62M(-6.4%)
Sep 2024
-
$892.93M(+30.4%)
Jun 2024
-
$684.92M(-3.7%)
Mar 2024
-
$711.20M(+80.1%)
Dec 2023
$394.97M(-19.4%)
$394.97M(-0.1%)
Sep 2023
-
$395.54M(-9.2%)
Jun 2023
-
$435.43M(-5.8%)
Mar 2023
-
$462.00M(-5.7%)
Dec 2022
$490.15M
$490.15M(-4.4%)
DateAnnualQuarterly
Sep 2022
-
$512.88M(+28.9%)
Jun 2022
-
$397.95M(-7.2%)
Mar 2022
-
$428.72M(-6.7%)
Dec 2021
$459.64M(+61.9%)
$459.64M(-4.9%)
Sep 2021
-
$483.13M(+87.2%)
Jun 2021
-
$258.10M(-6.2%)
Mar 2021
-
$275.25M(-3.0%)
Dec 2020
$283.89M(+718.7%)
$283.89M(-3.7%)
Sep 2020
-
$294.69M(+183.2%)
Jun 2020
-
$104.04M(+200.1%)
Dec 2019
$34.67M(-11.1%)
$34.67M
Dec 2018
$38.99M
-

FAQ

  • What is Kymera Therapeutics, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. annual shareholders equity year-on-year change?
  • What is Kymera Therapeutics, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. quarterly shareholders equity year-on-year change?

What is Kymera Therapeutics, Inc. annual stockholders equity?

The current annual shareholders equity of KYMR is $835.62M

What is the all-time high annual shareholders equity for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high annual stockholders equity is $835.62M

What is Kymera Therapeutics, Inc. annual shareholders equity year-on-year change?

Over the past year, KYMR annual stockholders equity has changed by +$440.65M (+111.56%)

What is Kymera Therapeutics, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of KYMR is $946.26M

What is the all-time high quarterly shareholders equity for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high quarterly stockholders equity is $971.48M

What is Kymera Therapeutics, Inc. quarterly shareholders equity year-on-year change?

Over the past year, KYMR quarterly stockholders equity has changed by +$53.33M (+5.97%)
On this page